ArticleThe Journal of biological chemistry2019

An engineered antibody fragment targeting mutant β-catenin via major histocompatibility complex I neoantigen presentation.

Michelle S Miller et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.